The role of nitric oxide in the pathogenesis of systemic and splanchnic vasodilation in cirrhotic rats before and after the onset of ascites

Background: The role of nitric oxide (NO) in the pathogenesis of splanchnic arterial vasodilation in cirrhosis has been recently debated by some experimental studies.

[1]  R. Schrier,et al.  Ascites and Renal Dysfunction in Liver Disease , 2005 .

[2]  J. Barberà,et al.  Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis , 2003, Hepatology.

[3]  Seham A. Abd El-Aleem,et al.  Expression of nitric oxide synthase isoforms in human liver cirrhosis , 2003, The Journal of pathology.

[4]  F. Serracino-Inglott,et al.  Hepatic and mesenteric nitric oxide synthase expression in a rat model of CCl(4)-induced cirrhosis. , 2003, The Journal of surgical research.

[5]  W. Jiménez,et al.  Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis. , 2003, The American journal of pathology.

[6]  J. Reichen,et al.  Endothelial, but not the inducible, nitric oxide synthase is detectable in normal and portal hypertensive rats. , 2002, Liver.

[7]  R. Groszmann,et al.  Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[8]  L. Spahr,et al.  Acute Effects of Nitric Oxide Synthase Inhibition on Systemic, Hepatic, and Renal Hemodynamics in Patients with Cirrhosis and Ascites , 2002, Journal of Investigative Medicine.

[9]  R. Martı́n-Ruiz,et al.  Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. , 2002, Gastroenterology.

[10]  E. Masini,et al.  Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis , 2001, Hepatology.

[11]  P. Cahill,et al.  Endothelial dysfunction in cirrhosis and portal hypertension. , 2001, Pharmacology & therapeutics.

[12]  W. Jiménez,et al.  Increased activity of guanosine 3′‐5′‐cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites , 2000, Hepatology.

[13]  R. Groszmann,et al.  Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. , 1999, The Journal of clinical investigation.

[14]  C. Chagneau,et al.  Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein‐stenosed rats after lipopolysaccharide administration , 1999, Hepatology.

[15]  H. Bonkovsky,et al.  Increased heme oxygenase‐1 gene expression in liver cells and splanchnic organs from portal hypertensive rats , 1999, Hepatology.

[16]  P. Angeli,et al.  Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide , 1999, Hepatology.

[17]  B. Davidson,et al.  Hepatic and splanchnic nitric oxide activity in patients with cirrhosis , 1999, Gut.

[18]  R. Groszmann,et al.  NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[19]  M. Álvarez-Mon,et al.  Factors mediating the hemodynamic effects of tumor necrosis factor-α in portal hypertensive rats. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[20]  R. Schrier,et al.  Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. , 1998, The New England journal of medicine.

[21]  P. Cahill,et al.  Enhanced cyclooxygenase‐1 expression within the superior mesenteric artery of portal hypertensive rats: Role in the hyperdynamic circulation , 1998, Hepatology.

[22]  J. Henriksen,et al.  Circulatory abnormalities in cirrhosis with focus on neurohumoral aspects. , 1997, Seminars in nephrology.

[23]  R. Groszmann,et al.  Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis. , 1996, Gastroenterology.

[24]  R. Schrier,et al.  Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. , 1995, Gastroenterology.

[25]  R. Moreau,et al.  Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis. , 1995, Journal of hepatology.

[26]  J. Rodés,et al.  Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. , 1995, Gastroenterology.

[27]  W. Jiménez,et al.  Nitric oxide production in arterial vessels of cirrhotic rats , 1995, Hepatology.

[28]  V. Arroyo,et al.  Increased nitric oxide—dependent vasorelaxation in aortic rings of cirrhotic rats with ascites , 1994, Hepatology.

[29]  O. Bulbena,et al.  Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia , 1993, Hepatology.

[30]  W. Jiménez,et al.  Impaired responsiveness to angiotensin II in experimental cirrhosis: Role of nitric oxide , 1993, Hepatology.

[31]  W. Jiménez,et al.  Brachial and femoral artery blood flow in cirrhosis: Relationship to kidney dysfunction , 1993, Hepatology.

[32]  R. Groszmann,et al.  Nω‐Nitro‐L‐arginine Administration Corrects Peripheral Vasodilation and Systemic Capillary Hypotension and Ameliorates Plasma Volume Expansion and Sodium Retention in Portal Hypertensive Rats , 1993 .

[33]  R. Groszmann,et al.  N omega-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. , 1993, Hepatology.

[34]  P. Pizcueta,et al.  Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. , 1992, Gastroenterology.

[35]  R. Moreau,et al.  Evidence for normal nitric oxide—mediated vasodilator tone in conscious rats with cirrhosis , 1992, Hepatology.

[36]  R. Groszmann,et al.  Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. , 1992, Gastroenterology.

[37]  R. Groszmann,et al.  In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. , 1992, The American journal of physiology.

[38]  W. Jiménez,et al.  Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxide , 1992, Hepatology.

[39]  Vicente Arroyo,et al.  Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis , 1988, Hepatology.